Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Aralez Pharmaceuticals received early financing of $75.0M on 2016-02-19.
| Series | Round size | Date |
|---|---|---|
| Debt | $75M | 02/2016 |
| Investors | Security type |
|---|---|
| JW Asset Management | Post-IPO Equity - Aralez Pharmaceuticals |
| Deerfield | Post-IPO Equity - Aralez Pharmaceuticals |
| Broadfin Capital | Post-IPO Equity - Aralez Pharmaceuticals |
| Novelion Therapeutics | Post-IPO Equity - Aralez Pharmaceuticals |
Aralez Pharmaceuticals's top competitor, Watson Pharma Pvt Ltd, earned an annual revenue of $5.9B.
Aralez Pharmaceuticals's smallest competitor is Eton Pharmaceuticals with revenue of $959.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Santarus | - | $218.0M | 290 | - |
| Watson Pharma Pvt Ltd | - | $5.9B | 21,600 | - |
| Pernix Therapeutics Holdings | - | $146.1M | 171 | - |
| Cadence Pharmaceuticals | - | $112.6M | 350 | - |
| Eagle Pharmaceuticals | - | $316.6M | 96 | - |
| Avenue Therapeutics | - | $2.0M | 4 | - |
| Tonix Pharmaceuticals | - | $12.7M | 26 | - |
| Eton Pharmaceuticals | - | $959,000 | 10 | - |
| Recro Pharma Inc. | - | $94.6M | 255 | - |
| Dova Pharmaceuticals | - | $10.4M | 115 | - |
Zippia gives an in-depth look into the details of Aralez Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Aralez Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Aralez Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Aralez Pharmaceuticals. The data presented on this page does not represent the view of Aralez Pharmaceuticals and its employees or that of Zippia.
Aralez Pharmaceuticals may also be known as or be related to ARALEZ PHARMACEUTICALS INC., Aralez Pharmaceuticals, Aralez Pharmaceuticals Inc, Aralez Pharmaceuticals Inc., Aralez Pharmaceuticals, Inc. and POZEN Inc.